Urology News

  • 'Alternative Medicine' for Cancer Ups Death Risk Cancer patients who reject conventional treatments and choose alternative treatments exclusively are rare and are rarely studied. New data are sobering.
  • Proton Therapy Insurance Coverage: Fair or Foul? At one center, the vast majority of requests for coverage for treatment of a set of cancers were approved, although some approvals required going through an appeal process. But was this well done?
 

Today on Medscape

Top Stories from Across Medicine

Top Medical News from Across Medscape

  • CMS to Reduce Audit Burden on PhysiciansNew program aims to 'review and educate' only certain providers who have billed Medicare for particular services; fewer claims will be audited.
  • Thromboembolism Risk Doubled in Cancer PatientsCancer patients are twice as likely as other patients to have an arterial thromboembolic event in the 6 months after diagnosis, although the increased risk disappears at 1 year, say US researchers.
  • Nationwide Recalls From Two Compounding PharmaciesThe products in question, made by Bella Pharmaceuticals and Vital Rx, were recalled voluntarily after the FDA identified manufacturing problems in recent inspections.
  • Alcohol's CV and Cancer Risk-Balancing Act: More EvidenceThe benefit was in both men and women, but the rise in all-cause mortality wasn't significant for women. "The J-shaped relationship between alcohol consumption and mortality risk cannot be dismissed."

Perspective

Business of Medicine

Columnists

Advisory Board

 

Medscape Editor-in-Chief

  • Eric J. Topol, MD Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute; Senior Consultant, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California; Editor-in-Chief, Medscape